{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:46:13Z","timestamp":1783511173665,"version":"3.55.0"},"reference-count":70,"publisher":"American Association for Cancer Research (AACR)","issue":"2","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002387","name":"National Cancer Institute, Cairo University","doi-asserted-by":"publisher","award":["CA197591"],"award-info":[{"award-number":["CA197591"]}],"id":[{"id":"10.13039\/501100002387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005188","name":"Tobacco-Related Disease Research Program","doi-asserted-by":"publisher","award":["T31FT1610"],"award-info":[{"award-number":["T31FT1610"]}],"id":[{"id":"10.13039\/100005188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pharmacologic restoration of p53 tumor suppressor function is a conceptually appealing therapeutic strategy for the many deadly cancers with compromised p53 activity, including lung adenocarcinoma. However, the p53 pathway has remained undruggable, partly because of insufficient understanding of how to drive effective therapeutic responses without toxicity. In this study, we use mouse and human models to deconstruct the transcriptional programs and sequelae underlying robust therapeutic responses in lung adenocarcinoma. We show that p53 drives potent tumor regression by direct Tsc2 transactivation, leading to mTORC1 inhibition and Transcription factor EB (TFEB) nuclear accumulation, which in turn triggers lysosomal gene expression programs, autophagy, and cellular senescence. Senescent lung adenocarcinoma cells secrete factors to recruit macrophages, precipitating cancer cell phagocytosis and tumor regression. Collectively, our analyses reveal a surprisingly complex cascade of events underlying a p53 therapeutic response in lung adenocarcinoma and illuminate targetable nodes for p53 combination therapies, thus establishing a critical framework for optimizing p53-based therapeutics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Cancer therapies based on targeting the p53 pathway remain elusive. To address this gap, we unravel the detailed sequence of events governing p53-induced tumor regression in lung adenocarcinoma. These analyses reveal a TSC2\u2013mTORC1\u2013TFEB axis underlying p53-driven senescence and tumor regression, which suggests new strategies to perfect p53-based combination therapies for lung adenocarcinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-25-0525","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T19:25:51Z","timestamp":1760988351000},"page":"391-411","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["p53 Drives Lung Cancer Regression through a TSC2\/TFEB-dependent Senescence Program"],"prefix":"10.1158","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8290-151X","authenticated-orcid":false,"given":"Mengxiong","family":"Wang","sequence":"first","affiliation":[{"name":"1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2601-0031","authenticated-orcid":false,"given":"Kathryn T.","family":"Bieging-Rolett","sequence":"additional","affiliation":[{"name":"1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2947-8547","authenticated-orcid":false,"given":"Alyssa M.","family":"Kaiser","sequence":"additional","affiliation":[{"name":"1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1674-3370","authenticated-orcid":false,"given":"Colleen A.","family":"Brady","sequence":"additional","affiliation":[{"name":"1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2727-6969","authenticated-orcid":false,"given":"John H.","family":"Lockhart","sequence":"additional","affiliation":[{"name":"2Department of Molecular Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida."},{"name":"3Cancer Biology and Evolution Program, H. Lee Moffitt Cancer Center, Tampa, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9535-2161","authenticated-orcid":false,"given":"Sofia","family":"Ferreira","sequence":"additional","affiliation":[{"name":"1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9191-8754","authenticated-orcid":false,"given":"Kha T.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-5816","authenticated-orcid":false,"given":"Arati","family":"Rajeevan","sequence":"additional","affiliation":[{"name":"1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4975-8747","authenticated-orcid":false,"given":"Simone A.","family":"Evans","sequence":"additional","affiliation":[{"name":"4Department of Genetics, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-7272","authenticated-orcid":false,"given":"Tianyu","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-3855","authenticated-orcid":false,"given":"Nitin","family":"Raj","sequence":"additional","affiliation":[{"name":"1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1981-1535","authenticated-orcid":false,"given":"Arielle","family":"Elkrief","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Laboratory Medicine, and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"6Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Department of Hemato-Oncology, University of Montr\u00e9al, Montreal, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5717-3856","authenticated-orcid":false,"given":"Sam E.","family":"Tischfield","sequence":"additional","affiliation":[{"name":"7Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9055-7213","authenticated-orcid":false,"given":"Marc","family":"Ladanyi","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Laboratory Medicine, and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8768-3812","authenticated-orcid":false,"given":"Michael G.","family":"Ozawa","sequence":"additional","affiliation":[{"name":"8Department of Pathology, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-4349","authenticated-orcid":false,"given":"Nam Q.","family":"Bui","sequence":"additional","affiliation":[{"name":"9Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8962-3527","authenticated-orcid":false,"given":"Christopher T.","family":"Chen","sequence":"additional","affiliation":[{"name":"9Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6173-2403","authenticated-orcid":false,"given":"Elsa R.","family":"Flores","sequence":"additional","affiliation":[{"name":"2Department of Molecular Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida."},{"name":"3Cancer Biology and Evolution Program, H. Lee Moffitt Cancer Center, Tampa, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1782-9045","authenticated-orcid":false,"given":"Laura D.","family":"Attardi","sequence":"additional","affiliation":[{"name":"1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California."},{"name":"4Department of Genetics, Stanford University School of Medicine, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"2026020910330850500_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"The Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"2026020910330850500_bib2","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1073\/pnas.1319963111","article-title":"Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma","volume":"111","author":"Sutherland","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020910330850500_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/joim.13201","article-title":"Alveolar progenitor cells and the origin of lung cancer","volume":"289","author":"Sainz de Aja","year":"2021","journal-title":"J Intern Med"},{"key":"2026020910330850500_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1146\/annurev.bi.56.070187.004023","article-title":"Ras genes","volume":"56","author":"Barbacid","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"2026020910330850500_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2020.06.012","article-title":"Emergence of a high-plasticity cell state during lung cancer evolution","volume":"38","author":"Marjanovic","year":"2020","journal-title":"Cancer Cell"},{"key":"2026020910330850500_bib6","first-page":"625","article-title":"Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers","volume":"8","author":"Tammemagi","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026020910330850500_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrclinonc.2017.151","article-title":"Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others","volume":"15","author":"Sabapathy","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2026020910330850500_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature09535","article-title":"Stage-specific sensitivity to p53 restoration during lung cancer progression","volume":"468","author":"Feldser","year":"2010","journal-title":"Nature"},{"key":"2026020910330850500_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nature09526","article-title":"Selective activation of p53-mediated tumour suppression in high-grade tumours","volume":"468","author":"Junttila","year":"2010","journal-title":"Nature"},{"key":"2026020910330850500_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"2026020910330850500_bib11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/humu.23035","article-title":"TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data","volume":"37","author":"Bouaoun","year":"2016","journal-title":"Hum Mutat"},{"key":"2026020910330850500_bib12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1158\/2159-8290.CD-16-1337","article-title":"Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies","volume":"7","author":"Jordan","year":"2017","journal-title":"Cancer Discov"},{"key":"2026020910330850500_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"2026020910330850500_bib14","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1016\/j.febslet.2014.03.049","article-title":"Wild type p53 reactivation: from lab bench to clinic","volume":"588","author":"Selivanova","year":"2014","journal-title":"FEBS Lett"},{"key":"2026020910330850500_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","article-title":"Drugging p53 in cancer: one protein, many targets","volume":"22","author":"Hassin","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"2026020910330850500_bib16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/pharmrev.123.001026","article-title":"MDM2 inhibitors for cancer therapy: the past, present, and future","volume":"76","author":"Wang","year":"2024","journal-title":"Pharmacol Rev"},{"key":"2026020910330850500_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41571-022-00671-9","article-title":"The current state of the art and future trends in RAS-targeted cancer therapies","volume":"19","author":"Punekar","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2026020910330850500_bib18","doi-asserted-by":"crossref","first-page":"e201908212","DOI":"10.1083\/jcb.201908212","article-title":"p53 deficiency triggers dysregulation of diverse cellular processes in physiological oxygen","volume":"219","author":"Valente","year":"2020","journal-title":"J Cell Biol"},{"key":"2026020910330850500_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.tcb.2020.12.011","article-title":"p53 and tumor suppression: it takes a network","volume":"31","author":"Boutelle","year":"2021","journal-title":"Trends Cell Biol"},{"key":"2026020910330850500_bib20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41586-023-06253-8","article-title":"p53 governs an AT1 differentiation programme in lung cancer suppression","volume":"619","author":"Kaiser","year":"2023","journal-title":"Nature"},{"key":"2026020910330850500_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrm4007","article-title":"p53 in survival, death and metabolic health: a lifeguard with a licence to kill","volume":"16","author":"Kruiswijk","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026020910330850500_bib22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2012.04.026","article-title":"Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence","volume":"149","author":"Li","year":"2012","journal-title":"Cell"},{"key":"2026020910330850500_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41568-024-00679-6","article-title":"Combinatorial strategies to target RAS-driven cancers","volume":"24","author":"Perurena","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"2026020910330850500_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cell.2011.03.035","article-title":"Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression","volume":"145","author":"Brady","year":"2011","journal-title":"Cell"},{"key":"2026020910330850500_bib25","doi-asserted-by":"crossref","first-page":"17123","DOI":"10.1073\/pnas.1111245108","article-title":"Full p53 transcriptional activation potential is dispensable for tumor suppression in diverse lineages","volume":"108","author":"Jiang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020910330850500_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ccell.2017.09.007","article-title":"A p53 super-tumor suppressor reveals a tumor suppressive p53-Ptpn14-Yap axis in pancreatic cancer","volume":"32","author":"Mello","year":"2017","journal-title":"Cancer Cell"},{"key":"2026020910330850500_bib27","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1038\/s41598-020-60272-3","article-title":"Generation of a conditional Flpo\/FRT mouse model expressing constitutively active TGF\u03b2 in fibroblasts","volume":"10","author":"Cardot-Ruffino","year":"2020","journal-title":"Sci Rep"},{"key":"2026020910330850500_bib28","first-page":"397","article-title":"Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice","volume":"5","author":"Lee","year":"2012","journal-title":"Dis Model Mech"},{"key":"2026020910330850500_bib29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05541","article-title":"Restoration of p53 function leads to tumour regression in vivo","volume":"445","author":"Ventura","year":"2007","journal-title":"Nature"},{"key":"2026020910330850500_bib30","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.athoracsur.2010.12.028","article-title":"Tumor necrosis as a prognostic factor for stage IA non-small cell lung cancer","volume":"91","author":"Park","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"2026020910330850500_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41698-023-00419-3","article-title":"Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)","volume":"7","author":"Lockhart","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"2026020910330850500_bib32","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/35074129","article-title":"Somatic activation of the K-ras oncogene causes early onset lung cancer in mice","volume":"410","author":"Johnson","year":"2001","journal-title":"Nature"},{"key":"2026020910330850500_bib33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1101\/gad.212282.112","article-title":"Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses","volume":"27","author":"Kenzelmann Broz","year":"2013","journal-title":"Genes Dev"},{"key":"2026020910330850500_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41598-021-03875-8","article-title":"Robust LC3B lipidation analysis by precisely adjusting autophagic flux","volume":"12","author":"Liebl","year":"2022","journal-title":"Sci Rep"},{"key":"2026020910330850500_bib35","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/s41418-022-01028-6","article-title":"Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease","volume":"29","author":"Tan","year":"2022","journal-title":"Cell Death Differ"},{"key":"2026020910330850500_bib36","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"Palmieri","year":"2011","journal-title":"Hum Mol Genet"},{"key":"2026020910330850500_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41420-024-01850-6","article-title":"From the regulatory mechanism of TFEB to its therapeutic implications","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov"},{"key":"2026020910330850500_bib38","doi-asserted-by":"crossref","first-page":"775507","DOI":"10.3389\/fcell.2021.775507","article-title":"The cross talk between p53 and mTOR pathways in response to physiological and genotoxic stresses","volume":"9","author":"Cui","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026020910330850500_bib39","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1101\/gad.519709","article-title":"Autophagy mediates the mitotic senescence transition","volume":"23","author":"Young","year":"2009","journal-title":"Genes Dev"},{"key":"2026020910330850500_bib40","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1242\/dev.02820","article-title":"Met acts on Mdm2 via mTOR to signal cell survival during development","volume":"134","author":"Moumen","year":"2007","journal-title":"Development"},{"key":"2026020910330850500_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-4939-2522-3_10","article-title":"Measuring autophagy in stressed cells","volume":"1292","author":"Sharifi","year":"2015","journal-title":"Methods Mol Biol"},{"key":"2026020910330850500_bib42","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1021\/jm401753e","article-title":"Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development","volume":"57","author":"Sun","year":"2014","journal-title":"J Med Chem"},{"key":"2026020910330850500_bib43","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jtho.2023.05.007","article-title":"Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification","volume":"18","author":"Elkrief","year":"2023","journal-title":"J Thorac Oncol"},{"key":"2026020910330850500_bib44","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.1073\/pnas.0905299106","article-title":"Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6\/IL-8 cytokine network","volume":"106","author":"Orjalo","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020910330850500_bib45","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.cell.2008.03.038","article-title":"Chemokine signaling via the CXCR2 receptor reinforces senescence","volume":"133","author":"Acosta","year":"2008","journal-title":"Cell"},{"key":"2026020910330850500_bib46","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","article-title":"Exploiting senescence for the treatment of cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"2026020910330850500_bib47","doi-asserted-by":"crossref","first-page":"e202010162","DOI":"10.1083\/jcb.202010162","article-title":"Similarities and interplay between senescent cells and macrophages","volume":"220","author":"Behmoaras","year":"2021","journal-title":"J Cell Biol"},{"key":"2026020910330850500_bib48","doi-asserted-by":"crossref","first-page":"e2019740118","DOI":"10.1073\/pnas.2019740118","article-title":"Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration","volume":"118","author":"S\u00e1nchez-Rivera","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020910330850500_bib49","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature05529","article-title":"Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas","volume":"445","author":"Xue","year":"2007","journal-title":"Nature"},{"key":"2026020910330850500_bib50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1158\/2159-8290.CD-22-0528","article-title":"Senescence rewires microenvironment sensing to facilitate antitumor immunity","volume":"13","author":"Chen","year":"2023","journal-title":"Cancer Discov"},{"key":"2026020910330850500_bib51","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.molcel.2020.10.022","article-title":"Zmat3 is a key splicing regulator in the p53 tumor suppression program","volume":"80","author":"Bieging-Rolett","year":"2020","journal-title":"Mol Cell"},{"key":"2026020910330850500_bib52","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41419-020-03066-9","article-title":"Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis","volume":"11","author":"Best","year":"2020","journal-title":"Cell Death Dis"},{"key":"2026020910330850500_bib53","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41418-023-01249-3","article-title":"Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses","volume":"31","author":"La Marca","year":"2024","journal-title":"Cell Death Differ"},{"key":"2026020910330850500_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1101\/gad.340919.120","article-title":"mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression","volume":"35","author":"Kon","year":"2021","journal-title":"Genes Dev"},{"key":"2026020910330850500_bib55","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/onc.2013.589","article-title":"p53 suppresses carcinoma progression by inhibiting mTOR pathway activation","volume":"34","author":"Akeno","year":"2015","journal-title":"Oncogene"},{"key":"2026020910330850500_bib56","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","article-title":"The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways","volume":"67","author":"Feng","year":"2007","journal-title":"Cancer Res"},{"key":"2026020910330850500_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2017.02.003","article-title":"When the guardian sleeps: reactivation of the p53 pathway in cancer","volume":"773","author":"Merkel","year":"2017","journal-title":"Mutat Res Rev Mutat Res"},{"key":"2026020910330850500_bib58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-pathol-042320-025840","article-title":"A balancing act: p53 activity from tumor suppression to pathology and therapeutic implications","volume":"17","author":"Wang","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"2026020910330850500_bib59","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.22.01285","article-title":"A first-in-human phase I study of milademetan, an MDM2 inhibitor, in patients with advanced liposarcoma, solid tumors, or lymphomas","volume":"41","author":"Gounder","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026020910330850500_bib60","doi-asserted-by":"crossref","first-page":"a026245","DOI":"10.1101\/cshperspect.a026245","article-title":"Targeting the MDM2-p53 protein-protein interaction for new cancer therapy: progress and challenges","volume":"7","author":"Wang","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026020910330850500_bib61","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1158\/2159-8290.CD-23-0866","article-title":"Epigenetic and oncogenic inhibitors cooperatively drive differentiation and kill KRAS-mutant colorectal cancers","volume":"14","author":"Loi","year":"2024","journal-title":"Cancer Discov"},{"key":"2026020910330850500_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng1498","article-title":"The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality","volume":"37","author":"Johnson","year":"2005","journal-title":"Nat Genet"},{"key":"2026020910330850500_bib63","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1101\/gad.943001","article-title":"Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras","volume":"15","author":"Jackson","year":"2001","journal-title":"Genes Dev"},{"key":"2026020910330850500_bib64","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/nprot.2009.95","article-title":"Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase","volume":"4","author":"DuPage","year":"2009","journal-title":"Nat Protoc"},{"key":"2026020910330850500_bib65","doi-asserted-by":"crossref","first-page":"10280","DOI":"10.1158\/0008-5472.CAN-05-2193","article-title":"The differential effects of mutant p53 alleles on advanced murine lung cancer","volume":"65","author":"Jackson","year":"2005","journal-title":"Cancer Res"},{"key":"2026020910330850500_bib66","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.stem.2014.09.019","article-title":"m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells","volume":"15","author":"Batista","year":"2014","journal-title":"Cell Stem Cell"},{"key":"2026020910330850500_bib67","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.molcel.2022.04.010","article-title":"The Mettl3 epitranscriptomic writer amplifies p53 stress responses","volume":"82","author":"Raj","year":"2022","journal-title":"Mol Cell"},{"key":"2026020910330850500_bib68","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/cells10040852","article-title":"Simple and efficient protocol for subcellular fractionation of normal and apoptotic cells","volume":"10","author":"Senichkin","year":"2021","journal-title":"Cells"},{"key":"2026020910330850500_bib69","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41596-019-0128-8","article-title":"Protocol update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0)","volume":"14","author":"Mi","year":"2019","journal-title":"Nat Protoc"},{"key":"2026020910330850500_bib70","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-25-0525\/3661367\/cd-25-0525.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-25-0525\/3726006\/cd-25-0525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/16\/2\/391\/3731824\/cd-25-0525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/16\/2\/391\/3731824\/cd-25-0525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:33:33Z","timestamp":1770651213000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/2\/391\/772121\/p53-Drives-Lung-Cancer-Regression-through-a-TSC2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":70,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,21]]},"published-print":{"date-parts":[[2026,2,6]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-25-0525","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2159-8290.31296637","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296625","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296613","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296619","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296607","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276767","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276743","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276755","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276731","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276761","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276773","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276728","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276758","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296640","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296583","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296595","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296589","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296634","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296610","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276770","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296616","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296604","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296628","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276734","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276746","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276776","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276722","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276752","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276764","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276740","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276719","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276749","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296592","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276725","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31276737","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296580","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296586","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296574","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296601","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.31296631","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.c.8295315","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}